FATE
USDFate Therapeutics Inc. Common Stock
$1.160-0.010 (-0.855%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$1.170
High
$1.179
Low
$1.135
Volume
0.30M
Company Fundamentals
Market Cap
134.1M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
2.00M
Exchange
NGM
Currency
USD
52-Week Range
Low $0.66Current $1.160High $5.92
Related News
GlobeNewswire
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.